Put the service commitment inside the business decision

I examine an expansion proposal alongside the condition of the service already operating. When three centres together recorded ₹1.8 crore operating loss, we deferred two proposed openings with ₹9.6 crore planned expenditure and funded a separate ₹2.2 crore access and staffing programme. The following year's combined loss was ₹0.9 crore, which remained a loss and could not be attributed entirely to the programme. I want the board to understand both the opportunity postponed and the obligation being addressed. Deferral is not automatically a saving, because the proposed business and its future returns have also been postponed. The decision requires a clear account of what the existing centres need, who is responsible and what evidence would justify returning to expansion without simply treating a new location as an answer to an older operating problem.

I ask finance and service teams to explain what happens to a prepaid amount when the associated account closes. Our review of 186 closed accounts found twenty-four with unused balances totalling ₹18.6 lakh, which we returned. The clinical decision about whether care should continue remained separate from the business's treatment of the payment. I do not want a commercial process to create pressure for visits merely because money is already held. The useful account identifies the balance, the service actually provided, the responsible review and the communication with the person concerned. It should also reveal where a case remains disputed or incomplete. This is a method for examining a service obligation, not a claim that one review established the treatment of every account or replaced the company's legal and accounting advice.

A remuneration structure can influence behaviour even when the company has not measured a resulting clinical effect. We removed a paid-visit-linked component for eighty-two therapists and accepted an additional ₹1.35 crore annual compensation expense. The medical director retained authority over clinical standards and individual care. I supported the change because the commercial incentive deserved examination, not because I could claim that every prior decision had been inappropriate or that outcomes had improved after the change. Staff terms, implementation and financial consequences needed explicit ownership. I want management to distinguish the reason for changing an incentive from evidence of the later effect. That allows the business to act on a recognised conflict while remaining honest about what it has and has not established through observation.

When two centre leases required relocation, the property decision did not settle the arrangements of 112 people actively using those centres. Clinical teams and patients reviewed the appropriate options. At the transition checkpoint, seventy-two had agreed an arrangement at a nearby Orthevani centre, twenty-four had chosen an outside provider and sixteen remained unresolved. We funded ₹46 lakh for a ninety-day transition and kept responsibility for follow-up explicit. Those counts describe agreed arrangements at a point in time, not evidence of clinical continuity or successful treatment. I would not let a completed lease move become shorthand for every patient being safely transferred. The chief executive's role is to fund and account for the service commitment while qualified professionals and the people concerned make the decisions that the property plan cannot make for them.